• Latest Posts

Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia

French Pleodrug for Rare Neurological Disease opens up phase III trial in US

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

UK Cannabis Biotech gets another Orphan Drug Designation by the FDA

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

ADVERTISEMENT

It’s World Parkinson’s Disease Day! #EndParkinsons

French Biotech gets €34M to bring Multiple Sclerosis Drug to the US

Allergan Signs Massive €3Bn Alzheimer’s Deal with UK Biotech

Leading German Biotech recruits New talent for Fight against Alzheimer’s

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

Reviewing Autism: Can Biotech open up New Horizons?

ADVERTISEMENT